Coronavirus Update:What patients and families need to know
Review Process and Scoring Criteria
The written proposal format is listed below. A subset of submissions will be asked to prepare a 10-minute presentation as noted under the above Key Dates section. Those notified must be prepared to present live at the final competition.
Scoring by the judges will be based on an assessment of the following factors:
- Clinical significance of the pediatric product and its innovation
- Product development plan and feasibility
- Likelihood of commercialization
- Project team, environment and resources
- Potential for additional funding
This funding is intended to promote the commercialization of a pediatric medical product. The application should include a description of the long term funding strategy and product’s exit strategy. Applicants are encouraged to address how this funding will be used to advance a specific aspect of product development in the overall development plan.
The success of the Pediatric Innovation Fund will be measured by advancement through the product development progress, generation of intellectual property, clinical trials progress, steps toward FDA approval, follow-on funding and clinical impact.
Awardees will be required to submit three quarterly progress reports and a final report. Investigators that do not submit this report will be at risk of losing continued funding support.
Applicants must be up to date with, or able to obtain Institutional Review Board (IRB) or Institutional Animal Care and Use Committee (IACUC) approval for work proposed, if applicable. Any additional relevant certifications (FWA numbers, CITI certifications, etc.) must be made available upon request.